All In Biotech

Free tool

FAERS Monitor: Testim

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021454 or its brand name (Testim, Testosterone). Reports on generic versions are filed under their own applications.

Reports

22,552

Serious

13,806

61% of reports

Hospitalization

6,137

Death reported

1,106

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,566
  • off label use1,302
  • fatigue1,272
  • pain1,223
  • myocardial infarction949
  • nausea925
  • anxiety923
  • headache858
  • deep vein thrombosis817
  • pulmonary embolism800
  • cerebrovascular accident783
  • asthenia678
  • diarrhoea644
  • dizziness635
  • dyspnoea614

Reports by year received

View as table
YearReports
2004170
2005138
2006147
2007176
2008210
2009284
2010351
2011396
2012956
2013429
2014787
20152,259
20161,925
20171,307
20181,442
20191,318
20201,254
20211,237
20221,450
20231,565
20241,651
20251,724
20261,376

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,031,607 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
deep vein thrombosisSignal81711.911.18,039
pulmonary embolismSignal8007.97.44,803
myocardial infarctionSignal9495.14.83,129
cerebrovascular accidentSignal7834.34.02,006
anxietySignal9233.02.81,267
pain1,2231.91.8498
asthenia6781.71.6190
fatigue1,2721.51.4238
off label use1,3021.41.3146
headache8581.31.253
dizziness6351.21.119
drug ineffective1,5661.11.118
nausea9251.11.07
dyspnoea6141.00.90
diarrhoea6440.90.93

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.